386 related articles for article (PubMed ID: 26702748)
1. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
[TBL] [Abstract][Full Text] [Related]
2. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
Zaki M; Amr K
Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
[TBL] [Abstract][Full Text] [Related]
5. Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men.
Son KY; Son HY; Chae J; Hwang J; Jang S; Yun JM; Cho B; Park JH; Kim JI
Lipids Health Dis; 2015 Sep; 14():105. PubMed ID: 26365620
[TBL] [Abstract][Full Text] [Related]
6. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
7. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
Novotny D; Vaverkova H; Karasek D; Malina P
Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.
Kim M; Kim M; Yoo HJ; Bang YJ; Lee SH; Lee JH
Clin Genet; 2018 Nov; 94(5):438-444. PubMed ID: 30132804
[TBL] [Abstract][Full Text] [Related]
10. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
11. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome.
Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B
Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219
[TBL] [Abstract][Full Text] [Related]
12. The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases.
Fahrioğlu U; Ergören MÇ
Biochem Genet; 2018 Jun; 56(3):176-187. PubMed ID: 29264753
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population.
Vasilopoulos Y; Sarafidou T; Bagiatis V; Skriapa L; Goutzelas Y; Pervanidou P; Lazopoulou N; Chrousos GP; Mamuris Z
Genet Test Mol Biomarkers; 2011 Sep; 15(9):613-7. PubMed ID: 21473680
[TBL] [Abstract][Full Text] [Related]
14. Association of a Vascular Endothelial Growth Factor genetic variant with Serum VEGF level in subjects with Metabolic Syndrome.
Ghazizadeh H; Fazilati M; Pasdar A; Avan A; Tayefi M; Ghasemi F; Mehramiz M; Mirhafez SR; Ferns GA; Azimi-Nezhad M; Ghayour-Mobarhan M
Gene; 2017 Jan; 598():27-31. PubMed ID: 27984191
[TBL] [Abstract][Full Text] [Related]
15. Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans.
Cha S; Yu H; Park AY; Song KH
Lipids Health Dis; 2014 Mar; 13():45. PubMed ID: 24618354
[TBL] [Abstract][Full Text] [Related]
16. Influences of APOA5 variants on plasma triglyceride levels in Uyghur population.
Li S; Hu B; Wang Y; Wu D; Jin L; Wang X
PLoS One; 2014; 9(10):e110258. PubMed ID: 25313938
[TBL] [Abstract][Full Text] [Related]
17. Heritability of the metabolic syndrome and its components in the Tehran Lipid and Glucose Study (TLGS).
Zarkesh M; Daneshpour MS; Faam B; Fallah MS; Hosseinzadeh N; Guity K; Hosseinpanah F; Momenan AA; Azizi F
Genet Res (Camb); 2012 Dec; 94(6):331-7. PubMed ID: 23374242
[TBL] [Abstract][Full Text] [Related]
18. Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.
Chien KL; Hsu HC; Chen YC; Su TC; Lee YT; Chen MF
Transl Res; 2009 Sep; 154(3):133-41. PubMed ID: 19665689
[TBL] [Abstract][Full Text] [Related]
19. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
20. Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population.
Lin E; Kuo PH; Liu YL; Yang AC; Kao CF; Tsai SJ
Sci Rep; 2016 Nov; 6():36830. PubMed ID: 27827461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
